25 Years of Equine Regenerative Medicine — An Honest Panel Discussion

Twenty-five years ago, stem cell therapy entered equine practice with considerable promise. A quarter of a century on, we’re bringing together three leading voices for an open, evidence-based conversation about what’s actually been learned.

This isn’t a sales pitch, and it isn’t a series of presentations. It’s a genuine discussion between colleagues — looking honestly at where stem cell therapy has added real value, where the evidence has been less convincing than expected, and where the field is heading next.

Joining the panel:

• Dr Sue Dyson — World-leading authority on equine lameness and poor performance
• Dr Almudena Pradera — Founder & Chief Scientific Officer, EquiCord; developer of HorStem® and DogStem®
• Dr Manuel Parache — Equine Veterinarian and Sports Medicine Specialist
• Dr Simon Constable — Owner and Lead Veterinarian at Simon Constable’s Equine Vets

Chaired by Greg McGarrell, who was involved in the original development of equine stem cell therapy 25 years ago.

Topics under discussion:

• Have stem cells lived up to the expectations of 25 years ago?
• Where does the published evidence genuinely support their use — and where does it fall short?
• How has the science evolved since the early days?
• Patient selection: which cases benefit, and which probably don’t?
• Tendon injuries and osteoarthritis — has the evidence held up?
• Where do stem cells now sit alongside PRP, ACS and polyacrylamide hydrogels?
• What’s next: improved cell therapies, cell-free biologics, exosomes or gene therapy?

📅 Tuesday 28 July, 18:30 (UK) / 19:30 (CET) 60 minutes of discussion, followed by 15 minutes of live audience questions.

Unable to join live? The full discussion will be made available afterwards as an on-demand recording.